# Bovine Chymotrypsin (Bos taurus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bovine-chymotrypsin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Enzyme
**Also Known As:** Chymotrypsin A, Bovine pancreatic chymotrypsin, Cattle chymotrypsin, α-Chymotrypsin, EC 3.4.21.1, Serine endopeptidase, Pancreatic chymotrypsin, Chymotrypsin from bovine pancreas

## Overview

Bovine chymotrypsin is a serine protease derived from Bos taurus pancreatic tissue that cleaves peptide bonds on the carboxyl side of aromatic and large hydrophobic amino acids including phenylalanine, tyrosine, and tryptophan. It functions via a catalytic triad (Ser195, His57, Asp102) to hydrolyze dietary proteins and has been studied for its role in pancreatitis models and milk protein [digestion](/ingredients/condition/gut-health).

## Health Benefits

• Protein digestion support - cleaves peptide bonds with high selectivity for aromatic residues (in vitro evidence only)
• May protect against pancreatitis severity by degrading trypsinogen (animal model evidence only)
• Assists in breaking down milk proteins including α-lactalbumin, β-lactoglobulin, and β-casein (in vitro evidence only)
• Natural [digestive enzyme](/ingredients/condition/gut-health) replacement for pancreatic insufficiency (theoretical benefit, no clinical evidence)
• Potential [anti-inflammatory](/ingredients/condition/inflammation) effects through protein breakdown (no direct clinical evidence)

## Mechanism of Action

Bovine chymotrypsin operates through a catalytic triad composed of serine-195, histidine-57, and aspartate-102, which facilitates nucleophilic attack on peptide bonds adjacent to aromatic residues (phenylalanine, tyrosine, tryptophan) and large hydrophobic residues (leucine, methionine). The enzyme forms an acyl-enzyme intermediate with the substrate before hydrolysis releases the cleaved peptide fragment and regenerates the active site. In pancreatic physiology, chymotrypsin also degrades trypsinogen, a proposed protective mechanism against premature protease activation and pancreatitis progression observed in animal models.

## Clinical Summary

Human clinical evidence for supplemental bovine chymotrypsin is limited, with most mechanistic data derived from in vitro enzyme kinetics and rodent studies. Animal model research has demonstrated that chymotrypsin-mediated degradation of trypsinogen can reduce severity markers of acute pancreatitis, though these findings have not been replicated in controlled human trials. In vitro studies confirm robust hydrolytic activity against milk proteins including α-lactalbumin and β-lactoglobulin, suggesting a potential role in dairy protein digestibility, but no large-scale randomized controlled trials (RCTs) with quantified clinical endpoints in humans have been published. The overall evidence quality is low-to-moderate, and claims beyond enzymatic mechanism remain preliminary.

## Nutritional Profile

Bovine chymotrypsin is a purified enzymatic protein derived from bovine pancreatic tissue, not a nutritional food ingredient. As a refined enzyme preparation, it contains negligible macronutrients in functional dosage forms. Protein content: chymotrypsin itself is a serine protease protein of approximately 25 kDa molecular weight, composed of 241 amino acids (three polypeptide chains A, B, C linked by disulfide bonds); at typical supplemental doses of 1–10 mg per serving, direct amino acid contribution is nutritionally insignificant. Carbohydrate content: essentially zero in purified form. Fat content: essentially zero in purified form. Micronutrients: no meaningful vitamin or mineral content inherent to the purified enzyme itself; however, the active site contains a catalytic triad of serine (Ser195), histidine (His57), and aspartate (Asp102) residues critical to function. Bioactive compounds: the primary bioactive is the enzyme itself, standardized by activity units (typically expressed as USP units or NF units; commercial preparations commonly range from 1,000–100,000 NF units per gram). Calcium dependency: chymotrypsin stability is enhanced by calcium ions, which maintain structural integrity of the enzyme at physiological temperatures. Bioavailability note: oral bioavailability of intact enzymatic activity is substantially limited by gastric acid denaturation and pepsin degradation; enteric coating or buffered formulations are required to preserve measurable activity reaching the small intestine; some evidence suggests partial absorption of peptide fragments but intact enzyme systemic absorption is minimal.

## Dosage & Preparation

No clinically studied dosage ranges for bovine chymotrypsin supplements are available. Research uses in vitro enzymatic assays (28 mM peptide bonds/s/mM enzyme) rather than human dosing studies. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Bovine chymotrypsin is generally considered low-risk when taken orally, as gastric acid and intestinal conditions denature much of the protein before systemic absorption, though individuals with known beef or bovine-derived product allergies should avoid it. Topical or ophthalmic formulations of chymotrypsin (used historically in cataract surgery) carry risks of uveitis and increased intraocular pressure, which are not applicable to oral supplemental use. Potential drug interactions include enhanced absorption or degradation of co-administered protein-based drugs or peptide hormones, and concurrent use with anticoagulants warrants caution given theoretical protease effects on clotting factor proteins. Safety data in pregnant or breastfeeding women is insufficient, and use in these populations is not recommended without medical supervision.

## Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses examining bovine chymotrypsin as a dietary supplement were identified. Research is limited to in vitro enzymatic assays showing hydrolysis of milk proteins and animal models (CTRB1-deficient mice) demonstrating protective effects against cerulein-induced pancreatitis severity.

## Historical & Cultural Context

No evidence of bovine chymotrypsin use in traditional medicine systems such as Ayurveda or Traditional Chinese Medicine was found. Its study and application are confined to modern biochemistry as a [digestive enzyme](/ingredients/condition/gut-health).

## Synergistic Combinations

Pancreatin, Bromelain, Papain, Betaine HCl, Ox Bile

## Frequently Asked Questions

### What is bovine chymotrypsin and what does it do?

Bovine chymotrypsin is a serine protease extracted from Bos taurus (cattle) pancreatic tissue that breaks down dietary proteins by cleaving peptide bonds on the carboxyl side of aromatic amino acids like phenylalanine, tyrosine, and tryptophan. It works via a catalytic triad (Ser195, His57, Asp102) and is used in supplements aimed at supporting protein digestion, particularly for dairy proteins such as α-lactalbumin and β-lactoglobulin.

### Is bovine chymotrypsin the same as trypsin?

No, bovine chymotrypsin and trypsin are distinct serine proteases with different substrate specificities. Trypsin cleaves peptide bonds after positively charged residues (lysine, arginine), while chymotrypsin preferentially targets aromatic and large hydrophobic residues (phenylalanine, tyrosine, tryptophan, leucine). Both are produced in the pancreas as inactive zymogens — chymotrypsinogen and trypsinogen respectively — and are activated in the small intestine.

### Can bovine chymotrypsin help with pancreatitis?

Animal model research suggests chymotrypsin may reduce pancreatitis severity by degrading trypsinogen, thereby limiting premature intrapancreatic trypsin activation, which is a key driver of pancreatic autodigestion. However, these findings come exclusively from rodent studies, and no controlled human clinical trials have confirmed this effect. Individuals with pancreatitis should not use chymotrypsin supplements without direct medical guidance.

### What foods or proteins does bovine chymotrypsin break down best?

Bovine chymotrypsin is particularly effective at hydrolyzing proteins rich in aromatic amino acids, including dairy proteins such as α-lactalbumin, β-lactoglobulin (both major whey components), and casein fractions. It also acts on meat proteins and soy proteins at phenylalanine, tyrosine, and tryptophan residues. In vitro studies confirm high catalytic efficiency (low Km values) against these substrates, though digestion in the human gut involves multiple proteases working simultaneously.

### What is the typical dosage of bovine chymotrypsin in supplements?

There is no established clinically validated dosage for supplemental bovine chymotrypsin in humans, as large-scale RCT data is lacking. Oral enzyme supplement formulations containing chymotrypsin typically include it as part of a multi-enzyme blend alongside trypsin, bromelain, and pancreatin, with chymotrypsin activity often expressed in USP units ranging from 100 to 1,000 USP units per dose. Dosing is largely empirical and manufacturer-specified, and activity levels can be significantly reduced by gastric acid without enteric coating.

### Is bovine chymotrypsin safe to take with pancreatic enzyme replacement medications?

Bovine chymotrypsin should not be combined with prescription pancreatic enzyme replacements without medical supervision, as both contain similar protease enzymes and concurrent use may lead to excessive enzyme activity. Consult your healthcare provider before adding bovine chymotrypsin to an existing pancreatic enzyme regimen to determine appropriate dosing and potential interactions. The combination may increase the risk of adverse effects or interfere with your doctor's ability to monitor enzyme replacement therapy effectiveness.

### Who should avoid taking bovine chymotrypsin supplements?

Individuals with diagnosed pancreatic conditions, cystic fibrosis, or those already taking pancreatic enzyme medications should avoid self-supplementing with bovine chymotrypsin without medical clearance. People with severe allergies to beef or bovine products should not use this supplement, as it is derived from cattle pancreatic tissue. Additionally, those taking anticoagulant medications should consult a healthcare provider, as proteolytic enzymes may have mild blood-thinning properties.

### How does the evidence for bovine chymotrypsin compare to human pancreatic enzymes?

While bovine chymotrypsin shows similar enzymatic activity to human pancreatic chymotrypsin in laboratory settings, current clinical evidence for human health benefits remains limited to animal models and in vitro studies. Human pancreatic enzyme extracts have substantially more clinical research supporting their use in pancreatic insufficiency, whereas bovine chymotrypsin's efficacy in humans has not been rigorously established through large-scale clinical trials. The structural similarity between bovine and human chymotrypsin suggests comparable function, but direct comparative human studies are lacking.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*